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CHAPTER 1 
GENERAL INTRODUCTION 
Microtubules and Microtubule-Associated Protein Tau 
Microtubules are major cytoskeletal structures found in 
eukaryotic cells. The main functions of microtubules include 
chromosome segregation in mitosis (1), intracellular 
transport (2), and providing cell support (3). This 
cytoskeleton is a hollow cylinder formed by the assembly of 
tubulin. Tubulin is mainly the associated product of two 
different subunits: a and 3 tubulin, y tubulins, another 
tubulin, are found only in the microtubule organizing center 
(4). a and P tubulins are highly conserved proteins (5). 
Both subunits have an approximate molecular mass of 50 kDa 
and contain about 450 amino acid residues with some 
variation depending on the isoforms (5). Results of 
proteolysis show that tubulin consists of at least two 
domains: an N-terminal domain which binds GTP, and a C-
terminal domain (including the acidic tail) which binds 
microtubule-associated proteins (6). Both a and P tubulins 
bind GTP but only P tubulin hydrolyzes GTP during microtubule 
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assembly (7). A 3-D structure for a and P tubulin revealed 
by electron crystallogragphy shows that they have similar 
conformation (8). "Dynamic instability" is a general 
property of microtubules (9) and is a consequence of the 
assembly-disassembly of microtubules. The assembly and 
disassembly of tubulin into microtubules are sensitive to 
the concentration of tubulin, temperature, pH, ion, GTP/GDP 
(10), hydrostatic pressure (11), microtubule poisons (such 
as colchicine) (12), and microtubule-associated proteins 
(13) . 
Microtubule-associated proteins (MAPs) are the proteins 
co-purified with tubulin during assembly-disassembly cycle 
during tubulin purification (13). There are several sub­
families in microtubule-associated protein family: MAPI, 
MAP2 (14), MAP3 (15), MAP4 (16), and tau (13). MAP2, MAP4, 
and tau have a long rod-like structure (13, 16). MAP2, 
MAP4, and tau are grossly similar in their domain structure 
(16, 17), that is composed of a microtubule-binding domain 
and a projection domain extending from the microtubule wall. 
Imperfect 18-mer repeats (consensus VXSKXGSXXNIKHXPGGG) are 
l o c a t e d  i n  t h e  m i c r o t u b u l e - b i n d i n g  d o m a i n  { 1 1 )  .  
Phosphorylation of microtubule-binding repeats in tau (18) 
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and mutation occurring within microtubule-binding repeats 
(19) can reduce tau's binding affinity for microtubules. 
Tau is enriched in neuronal cells (20). Tau promotes 
tubulin assembly, stabilizes microtubules, and nucleates 
microtubules in vitro (21, 22). The double 
immunofluorescent staining with tau antibodies (7A5 rabbit 
anti-tau) and tubulin antibodies (DMla mouse anti-tubulin) 
in PC12 cells show that tau and tubulin are colocalized 
(23), suggesting that ta.u binds to microtubules in vivo. 
Introduction of tau to cells can increase cellular 
microtubules (24) and promote neurite outgrowth (25). The 
addition of tau antisense oligonucleotides can block the 
neurite outgrowth in rat cerebellar neurons (26). In 
addition, the binding of tau also increases the stiffness of 
microtubules (27). 
In the human brain, tau exists as six isoforms and 
these forms are derived from a single gene in chromosome 17 
by different mRNA splicing reactions (28-31). The largest 
brain tau containing 441 amino acids possesses two N-
terminal inserts and four microtubule-binding repeats, but 
the smallest form possesses no N-terminal insert and has 
three microtubule-binding repeats instead (Fig. 1). The 
microtubule-binding repeats contain many basic residues and 
Figure 1. Bar diagrams and domain structures of six humcin 
brain tau isoforros. 1, 2, 3, 4 represent the 
microtubule-binding repeats. I and II are the N-
terminal inserts. 
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are believed to directly bind to the acidic C-terminal of 
tubulin to stabilize microtubules (6, 30). The tau 
structure for all isoforms is enriched with proline, 
glycine, and hydrophilic amino acids (30). The proline-rich 
region is next to the microtubule-binding repeats (Fig. 1). 
Results from the study using tau domain peptides- show that 
both the proline-rich region and the microtubule-binding 
region contribute to the binding affinity to microtubules 
(32) . 
Tau is an extended molecule rather than a globular 
protein. Early biophysical studies of tau using analytical 
centrifugation (13), electron microscopy (33), circular 
dichroism (CD) (34), and X-ray solution scattering (35) 
suggested that tau is a highly flexible extended molecule 
with little secondary structure. This view was confirmed by 
^H-NMR spectroscopy (36). This extended structure with 
little secondary structure may explain why tau is a heat-
stable, acid-stable protein (30). 
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Phosphorylation and Tau 
Protein phosphorylation is a post-translational 
modification which transfers the y-phosphate of ATP into a 
serine, theonine, or tyrosine residue in proteins and can 
change the protein's properties (37). Phosphorylation can 
change the characteristics of tau. Studies by Hagestedt et 
al. using paracrystal imaging showed that a change of 
flexibility of tau is caused by phosphorylation with 
Ca^^'/calmodulin-dependent kinase (38) . Tau becomes long and 
stiff after phosphorylation (38). Phosphorylation also 
reduces tau's ability to stimulate microtubule assembly 
(39). Phosphorylation on the microtubule-binding domain of 
tau can abolish tau's binding affinity (18) and cause 
microtubule disruption (40). 
Tau possesses many different phosphorylation sites and 
at least 25 sites have been identified in paired-helical 
filaments (PHFs) which are mainly composed of tau (Table 
1)(41, 42). PHF is one of the main hallmarks of Alzheimer's 
disease brains (43, 44). All are Ser/Thr phosphorylation 
sites. Phosphorylation of those sites by various protein 
kinases (Table 1), in general, can be classified as proline-
directed phosphorylation and non-proline-directed 
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Table 1. Phosphorylation sites of tau and acting kinases. 
GSK-3a GSK-3P CDC2 CDK5 MAPK PKA PKC CaMKII MARK 
SP 46 X 
TP 181 X 
S 198 
SP 199 X X 
SP 2 02 X X X 
TP 205 X X 
S 208 
S 210 
TP 212 
S 214 X 
TP 217 
TP 231 X X X X 
SP 235 X X X X X 
S 262 X X X X X 
S 324 X X X 
S 356 X X X 
SP 396 X X X 
S 400 X 
T 403 
SP 404 X X X 
S 409 X 
S 412 
S 413 X 
S 416 X 
SP 422 X 
Abbreviations: GSK-3 (a or P): glycogen synthase kinase-3; CDC2: cyclin 
dependent kinase 2; CDK5: cyclin-dependent kinase 5; MAPK: mitogen-
activated protein kinase; PKA, cyclic-AMP dependent protein kinase; PKC: 
protein kinase C; CaMKII: Ca/calmodulin-dependent protein kinase II; 
MARK: microtubule-associated protein/microtubule affinity regulating 
kinase. 
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phosphorylation (42, 45). Both types of phosphorylation can 
affect tau's function. For example, activation of mitogen-
activated protein kinase (46), glycogen synthase kinase-3 
(47), or microtubule-associated protein/microtubule 
regulating kinase (48) can phosphorylate intracellular tau 
and cause microtubule disruption. A recent study shows that 
tyrosine of tau can be phosphorylated by tyrosine kinase fyn 
(49) . 
In addition to kinases, hypoactive protein phosphatases 
are also proposed to relate to the consequence of 
hyperphosphorylation on tau. Hyperphosphorylation on tau 
occurs in Alzheimer's disease brains (43, 44). Protein 
phosphatase 1 and 2A are associated with microtubules and 
are capable of dephosphorylating tau (50, 51). Protein 
phosphatase 2B is also colocalized with microtubules and 
regulates the phosphorylation of tau in vivo (52). 
Inhibitors to PPl or PP2A, such as okadaic acid and 
calyculin A, can result in hyperphosphorylation of tau, 
which reduce binding ability to microtubules and promote 
microtubule disruption (50, 51). Cyclosporin A or a 
specific peptide, both of which inhibit PP2B activity, 
changes the phosphorylation state of tau and prevents axonal 
elongation in dissociated rat cerebellum cells (52). If 
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phosphorylated tau is dephosphorylated with PPl, PP2A, or 
PP2B, tau can recover its ability to promote tubulin 
assembly (39). 
Organic Osmolyte Methylamines 
Water-stressed cells accumulate small organic molecules 
to maintain cellular osmotic balance and cell morphology 
(53-56). Those small osmolytes are generally categorized 
into three groups: amino acids and their derivatives, 
polyols, and methylamines (Table 2). Molecules of the first 
two groups are "compatible osmolytes" which means cells 
accumulate those osmolytes to high concentrations without 
significantly perturbing protein functions. The third group 
of osmolytes is referred to as "counteracting osmolytes" for 
their counteracting effect on reversing the perturbations 
caused by urea. 
Methylamine osmolytes are commonly found in many urea-
rich tissues, such as the muscle of elasmobranchs (53, 54), 
coelacanth (53, 54), moridase and macrouridae (57), and the 
mammalian kidney (56). The concentrations of urea and 
methylamines form an approximately 2:1 ratio in many marine 
Table 2. Common cellular osmolytes 
I.Amino acid and derivatives 2.Polyols 3 .Methylamines 
Alanine Glycerol Betaine 
Proline Sorbitol Trimethylamine N-oxide 
Glutamic acid Mannose Glyc eroIphosphocho1ine 
y-Aminobutyric acid Sucrose Sarcosine 
Taurine Myo-inositol 
Mannitol 
Arabitol 
Trehalose 
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animals (53, 54, 57). Trimethylamine N-oxide (TMAO), a 
methylamine osmolyte, can be found at concentrations up to 
200 iiiM in elasmobranchs including cartilaginous fishes, such 
as sharks and rays (51, 52). At this concentration, TMAO may 
counteract denaturation caused by urea, which reaches 
concentrations of up to 0.4 M in elasmobranchs (53). 
Several enzymatic kinetics studies have shown that when urea 
and TMAO are present in a 2:1 ratio TMAO can offset the urea 
protein perturbations on creatine kinase, pyruvate kinase, 
argininosuccinate lyase, and lactic dehydrogenase (53). 
TMAO has been reported to behave as a chemical chaperon 
(56). TMAO can force chemically modified RNase and mutant 
RNase, two inactive, unfolded proteins, to fold and to 
become active (59). RNase T1 with its disulfide bonds 
reduced and chemically derivatized and staphylococcal 
nuclease mutant protein (T62P) exist as unfolded 
biologically inactive structures (59). However, in the 
presence of TMAO these proteins become folded and 
biologically active. 
Possible mechanisms of action of methylamines on 
proteins have been extensively studied. Transition 
temperature (Tm) measurement for ribonuclease shows that 
TMAO raises the Tm but urea lowers the Tm (60) . When urea 
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and TMAO are present in a 2:1 ratio, the effects of urea and 
TMAO on the Tm were found to be essentially the algebraic 
sum of the their individual effects (60). TMAO acts as a 
co-solvent and causes preferential hydration on the surface 
of proteins (61-64). TMAO is excluded from the protein 
surface-this is called solvophobic effect (61-64) . TMAO, 
therefore, changes the energy states of proteins (59, 60). 
Furthermore, release of bound water molecules occurring 
during folding or in specific association reactions (63, 64) 
in the presence of TMAO also contributes to the favorable 
energetics. 
Rationale for My Research 
Microtubule assembly is inhibited by urea both in vitro 
(65) and in vivo (66). How urea-rich cells protect their 
microtubules from the deleterious effects caused by urea is 
not yet clear. The rationale for this study is based on 
the properties of TMAO, which include the abilities to 
promote protein folding and/or aggregation and refold 
unfolded proteins. Tau is an extended protein and 
aggregates with microtubules during tubulin assembly. A 
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previous study done by Sackett shows that TMAO can enhance 
tubulin self-assembly but molar TMAO is needed in the 
assembly (65). TMAO should be able to promote the 
aggregation of tau-tubulin. In addition, taxol, which is 
used to stabilize microtubules, reduces the amount of TMAO 
needed to promote tubulin assembly (65). It is likely that 
TMAO at a physiological level should be able to promote 
tubulin assembly in the presence of tau. Therefore, I first 
hypothesized that TMAO at 200 mM should promote microtubule 
assembly in the assistance of microtubule-associated 
proteins. Second hypothesis is, based on the ability to 
correct the function of modified proteins, that TMAO could 
change the properties of phosphorylated tau to promote 
tubulin assembly. The last asked question in this 
dissertation is whether the increase of microtubule assembly 
caused by TMAO in vitro can be reproduce in cells. 
Dissertation Organization 
The first chapter is a general introduction of this 
dissertation. The next three chapters are in the formats of 
journal papers. Chapter 2, which has been published in 
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Biochemical and Biophyical Research Communications, presents 
the first finding about the effects caused by methylamine 
osmolytes on tau-microtubule assembly in vitro. Chapter 3, 
which has been accepted by the Proceedings of National 
Academy of Sciences of the USA, discusses the compensation 
of the functional deficit of phosphorylated tau in the event 
of tau-microtubule assembly, using TMAO. Chapter 4, which 
will be submitted to the Journal of Cell Biology for 
publication, describes that TMAO can enhance cellular 
microtubule assembly in XRl glial cells. A general siammary 
and discussion of the entire dissertation and an outlook for 
further work are also offered in Chapter 5. The references 
cited in the general introduction and the general summary 
and discussion are listed in the general references. 
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CHAPTER 2 
NATURAL METHYLAMINE OSMOLYTES, TRIMETHYLAMINE N-
OXIDE AND BETAINE, INCREASE TAU-INDUCED 
POLYMERIZATION OF MICROTUBULES 
A paper published in Biochemical and Biophysical Research 
Communications 250:728-730 (1998) 
Huang-Chun Tseng and Donald J. Graves* 
Neuroscience Program, and Department of Biochemistry, 
Biophysics and Molecular Biology, Iowa State University, 
Ames, lA 50011 
Abstract 
The natural osmolyte trimethylamine N-oxide (TMAO) at 
2 00 mM increases the extent and the rate of formation of 
polymerized microtubule (MT) complex caused by tau. TMAO at 
this concentration has no effect on tubulin alone. Urea at 
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200 itiM blocks tubulin assembly caused by tau, but this 
inhibition can be reversed by an equal amount of TMAO. 
Besides TMAO, betaine, another natural osmolyte, was found 
to have the same effects on MT as TMAO. On the contrary/ 
glycerol (a carbohydrate osmolyte) and glycine (an amino 
acid osmolyte) do not increase tau-induced MT assembly. The 
mechanism by which TMAO and betaine enhance tau's 
effectiveness is not known, but physical studies suggest 
that the secondary structure of tau is not appreciably 
changed by 200 mM TMAO. This is the first report showing 
that natural osmolytes, TMAO and betaine, at a near 
physiological concentration, are able to stimulate tau-
induced tubulin assembly. 
Introduction 
Water-stressed cells accumulate small organic molecules 
to maintain cellular osmotic balance and cell morphology. 
Those small osmolytes are generally categorized into three 
groups: amino acids and their derivatives, carbohydrates, 
and methylamines (1). Molecules of the first two groups are 
"compatible osmolytes" which means cells accumulate those 
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osmolytes to high concentrations without significantly 
perturbing protein functions. The third group of osmolytes 
is referred to "counteracting osmolytes" for their 
counteracting effect reversing the perturbations caused by 
urea. 
One counteracting osmolyte is trimethylamine N-oxide 
(TMAO). This substance can be found at concentrations up to 
0.2 M in elasmobranchs including cartilaginous fishes, such 
as sharks and rays (2). At this concentration, TMAO may 
counteract denaturation caused by urea which reaches 
concentrations of up to about 0.4 M in elasmobranchs. 
Mammalian kidneys may also accumulate urea at high 
concentrations. To adapt to this condition, renal medulla 
cells accumulate osmolytes such as betaine, sorbitol, 
inositol, and glycerophosphorylcholine (3). Among these, 
betaine, which is a methylamine compound, may counteract the 
denaturing effect of urea on proteins. 
Urea has previously been shown to inhibit in vitro 
taxol-stabilized microtubule (MT) assembly (3). 
Interestingly, TMAO reversed this urea-induced inhibition 
(3). These results suggest that TMAO may help to maintain 
the MT cytoskeleton in urea-rich cells. But how 
counteracting osmolytes work is still unknown. It may be 
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that TMAO could force some proteins to fold and to resist 
protein denaturation. Previous studies showed this osmolyte 
could force thermodynamically unfolded ribonuclease Tl to 
fold. Moreover, TMAO also can restore the biological 
function of the chemically modified ribonuclease Tl and the 
mutant nuclease through forcing protein structure refolding 
(4) . 
Among several factors affecting microtubule assembly, 
microtubule-associated proteins (MAPs) influence the process 
of nucleation, polymerization and maintenance during tubulin 
assembly (5, 6). Tau, a MAP, is enriched in neuronal axons 
and assists the polymerization of microtubules. However, if 
tau becomes hyperphosphorylated, it will not assist MT 
polymerization (7). This is significant since the 
hyperphosphorylated form of tau is a key component in an 
Alzheimer's disease hallmark, paired helical filament (8). 
As mentioned above, TMAO can force proteins to fold. It is 
not known whether the natural osmolytes could change tau's 
conformation and/or influence the strength of the 
interaction of tau with tubulin. 
In this report, we used an in vitro system with 
purified porcine brain tubulin and expressed human tau 
protein to investigate the roles of natural osmolytes in 
20 
MAPs-tubulin assembly. We also used this system to re­
evaluate the counteracting effects of natural osmolytes, 
including TMAO and betaine, etc., on the inhibition of 
assembly caused by urea. 
Materials and Methods 
Materials 
TMAO, betaine, urea, EGTA, EDTA, MOPS, MES, GTP, and 
glycine were purchased from Sigma; acetonitrile, glycerol, 
guanidine-HCl, NaCl, and MgClj from Fischer; dithiothreitol 
(DTT) from Boehringer Mannheim; protein assay reagent from 
Bio-Rad; and BL21 (DE3) E.coli cells from Novagen. 
Tau Protein 
A plasmid (T441-pRK172) with the longest human tau cDNA 
is provided by Dr. Iqbal from New York State Institutes for 
Basic Research in Developmental Disabilities. The plasmid 
is transformed into BL21(DE3) competent cells, following a 
procedure described in Novagen's pET system manual. The 
procedure protein expression follows a method described by 
Huang except that the protein induction is 4 hours (9). 
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Cell pellet collected from 1 liter culture was suspended 
with 1 ml of MOPS buffer containing 25 mM MOPS, pH 6.8, 1 mM 
EDTA, 1 mM EGTA, and 1 mM DTT. The cell suspension was 
lysed by sonication. Taking the advantage of heat stability 
of tau (10) , the tau lysate is heated to 80°C for 5 min. 
Protein aggregates were removed by centrifugation at 30,000g 
for 30 min at 4°C. Tau was further purified by two liquid 
chromatographic steps. A 5-ml HiTrap SP column (Pharmacia) 
equilibrated with the MOPS buffer is used to isolate tau. 
The bound tau is eluted using a linear NaCl gradient (0-500 
mM, 80 ml, in 40 min). The tau fractions are further 
purified with a C18 reverse-phase HPLC. A linear gradient 
from 0-50% of acetonitrile in water is used to bind 
proteins. The tau peak was collected, lyophilized and 
stored at -20°C. 
Porcine Brain Tubulin 
Fresh porcine brains were obtained from the Veterinary 
College, Iowa State University (ISU). Purification of 
porcine brain tubulin mainly followed the procedure by 
Williams and Lee (11). A 5-ml HiTrap SP (Pharmacia) column 
replaces the phosphocellulose column used by Williams and 
Lee. The solutions used in HiTrap chromatography are the 
22 
same as the solutions used in the Williams' method, except 
that P-mercaptoethanol was substituted by DTT. The flow rate 
in this method is 2 ml/min. Tubulins came out in the flow-
through fraction. The purified tubulin proteins were 
quickly frozen with liquid nitrogen and stored at -7 0°C. 
Tubulin Assembly 
To remove tubulin aggregates, thawed tubulin was 
centrifuged at 15,000 g for 10 min, at 4°C. This supernatant 
was used for assembly. The assembly condition was 10 mM 
tubulin, 1 mM GTP, 1 mM MgClj, 1 mM EGTA, and 0.1 mM EDTA in 
100 mM MES, pH 6.4 at 30°C. The concentrations of tau, 
osmolytes and urea are indicated in figure legends. The 
assembly was started by the addition of tubulin and the 
assembly process was monitored by following changes in 
absorbance at 350 nm using a Beckman DU640 
spectrophotometer. 
Protein Concentration Determination 
Porcine brain tubulin was dissolved in 6 M guanidine-
HCl and determined by photo-spectrometry at 275 nm. The 
extinction coefficient for tubulin in guanidine-HCl at 275 
nm is 1.03 ml/mg/ cm (12) . Tau concentration of tau was 
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measured by the Bradford method, using an interpolation in a 
standard curve of tau of which concentrations are estimated 
with amino acid analysis. The amino acid analysis was 
performed at the Protein Facility of ISU. 
Results 
Fig. 1 shows the effect of TMA.0 and tau on the 
polymerization of tubulin. Note that when tubulin is alone 
or in the presence of 200 mM TMAO in the assembly buffer 
there is little or no change in absorbance. No apparent 
tubulin assembly is observed in these two conditions. 
However, when 0.8 mM tau is added to the solution of tubulin 
(10 mM) the absorbance at 350 nm changes. The absorbance 
change is interpreted to mean that tubulin polymerization 
takes place under these conditions (13). When TMAO is added 
to the solution containing tubulin and tau, the rate and 
extent of change of absorbance appears to increase 
suggesting that TMAO changes the tubulin assembly process. 
Figure 1. The TMAO effect in tau-dependent tubulin assembly. 
Tubulin is incubated with 0.8 |iM tau in the 
assembly buffer at 3 0°C, without 200 mM TMAO (open 
circles) or with TMAO (closed circles). Tubulin 
without tau is incubated in the same condition, 
with TMAO (closed triangles) or without TMAO 
(closed squares). 
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To investigate how TMAO can affect the tau-induced 
polymerization of tubulin, we investigated the effects of 
TMAO on the extent and initial rate of tubulin 
polymerization at different concentrations of tau. The 
extent of the reaction was evaluated under the different 
conditions by measuring the absorbance at 350 nm after 15 
min. At this time, the absorbance change levels off, 
suggesting that the equilibrium position has been reached. 
Fig. 2A shows that in the absence of TMAO, the final 
change in absorbance at 3 50 nm can be described as a curve-
linear upward line. A curvature of this type is 
characteristic of a cooperative process. When TMAO is 
added, the curve is changed. Tubulin assembly with TMAO is 
increased, compared with that without TMAO. When comparing 
the changes caused by TMAO at low concentrations of tau, we 
found tau at 0.2 rtiM has no obvious effect on MT formation, 
but in the presence of 200 mM TMAO, it can promote MT 
formation effectively. In short, TMAO-tau can stimulate 
more MT formation than tau. 
TMAO also changes the kinetics of tau-tubulin assembly. 
The half time (ti/j) of total MT formation at various tau 
concentrations was determined. The results show that the t-^,2 
of the TMAO promoted reaction is shorter than that obtained 
Figure 2. A. Effect of TMAO on the extent of tau-tubulin 
formation. The changes of O.D. at 350 mti were 
deteirmined after 900 sec of a reaction. The 
square is the relationship of tau concentration 
and the total O.D. change which represents the 
amount of tau-microtubule at the equilibrium 
stage. The circle is the group with 200 mM TMAO. 
B. Effect of TMAO on the rate of foirmation of 
microtubules. T^/j was determined by measuring the 
time when half the amount of total microtubule was 
formed. The squares represent the group without 
TMAO, the circles, with TMAO. 
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without TMAO (Fig. 2B) . TMAO reduces the t-^,2 of the assembly-
process by approximately one-half when tau is in the range 
of 0.4 to 0.8 mM. For example, the t-^,2 values for the 
reaction of 0.8 mM tau with TMAO compared to the reactions 
without TMAO are about 170 sec and 340 sec, respectively. 
Thus, the decrease of ti^j indicates TMAO accelerates the rate 
of tau-tubulin assembly. 
On one hand, when comparing data in Fig. 2A and Fig. 
2B, we found 0.4 mM tau in TMAO generates a similar final 
amount tau-MT complex as 0.85 mM tau without TMAO (Fig. 2A). 
Meanwhile, the ti/2 of 0-4 mM tau with TMAO is similar to t^/2 
of 0.85 mM tau without TMAO (Fig. 2B). Above all, TMAO 
increases the extent of tau-induced assembly and the 
formation rate by increasing tau's effectiveness. The 
effectiveness of tau appears to be related to the binding 
affinity of tau. 
The mechanism by which TMAO affects tau-tubulin 
assembly is under investigation. TMAO has been proposed to 
force proteins to fold into thermodynamically favorable 
structures (4). We wondered whether TMAO could influence 
the conformation of tau. To test this, we utilized two 
different physical measurements, circular dichroism (CD) and 
photoacoustic Fourier transform infrared (FT-IR), to examine 
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conformational change of tau caused by TMAO. The 
preliminary results show no differences in signal of tau 
with or without TMAO (results not shown). 
Next, we investigated the effect of urea on tau-induced 
polymerization and whether TMAO could reverse the effect of 
urea. Fig. 3A shows the results obtained with low 
concentrations of TMAO and urea on tau-induced 
polymerization. The controls, tubulin alone or tubulin plus 
TMAO again show no change in absorbance with time. Closed 
circles of Fig. 3A shows the effect of tau, and the closed 
square of Fig. 3A shows that 200 mM urea inhibits the tau-
induced polymerization. With TMAO (200 mM) the largest 
change in absorbance is seen and that the combination of 
TMAO and urea gives a rate profile for what is seen for tau 
alone, i.e., TMAO overcomes the inhibitory effect of urea. 
In addition to our studies with TMAO, we also examined 
the effects of betaine, glycerol, and glycine. Betaine, one 
natural methylamine osmolyte found in mammalian renal cells, 
was also found to promote the extent of assembly and reverse 
the urea inhibition (Fig. 3B). The effects of betaine on 
tau-induced assembly are similar to those seen with TMAO. 
It increases the extent of polymerization and also 
accelerates the formation of tau-tubulin assembly. Like 
Figure 3. A. Effect of TMAO on the inhibition of assembly-
caused by urea. B. Effect of betaine on the 
inhibition of assembly caused by urea. The closed 
circles represent the tau-tubulin control; the 
open circles, with 200 itiM osmolyte (TMAO in A, or 
betaine in B); the squares, with 200 mM urea. The 
crosses represent tau-tubulin with the combination 
of 200 mM osmolyte and 200 mM urea. The reverse 
triangles represent the tubulin-alone control; the 
triangles, the tubulin-osmolyte. Tau is 0.8 |JM in 
both A and B. 
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TMAO, it does not stimulate MT formation when tau is absent. 
Note that the assembly with the equal combination of betaine 
and urea (crosses of Fig. 3B) is similar to the assembly 
with betaine (open circles of Fig. 3B), The rescuing effect 
by betaine seems more effective than that caused by TMAO 
when both osmolytes are at 200 mM. Other natural organic 
osmolytes, either 200 mM glycine, or 200 mM glycerol failed 
to stimulate tau-induced tubulin assembly (data not shown). 
In the controls for glycine and glycerol, neither of them 
can stimulate tubulin-alone assembly. 
Discussion 
Earlier, it was reported that TMAO at near 
physiological concentration could affect tubulin assembly 
but taxol, a microtubule-stabilizing agent, was needed for 
this effect. We observed that TMAO stimulated tau-induced 
tubulin assembly in the absence of taxol, but only if tau 
was included in the reaction mixture (Fig. 1). It has been 
reported that higher TMAO concentrations (> 700 mM) can 
stimulate tubulin-alone assembly (3). Because the assembly 
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stimulation needs tau, we suspect TMAO at lower 
concentrations could promote a tau-tubulin interaction. 
In the tau-induced tubulin assembly, tau concentration 
determines the polymerization. In Fig 2A, the final 
absorbance change increases with increasing tau. The 
effectiveness of tau can be roughly measured from the value 
of absorbance change at 350 nm/tau amount which presumably 
represents microtubule amount/tau amount, according to the 
turbidity measurement theory (13). Results shows that high 
tau is more effective in polymerization than low tau. The 
effectiveness of tau is not linearly proportional to its 
concentrations. This suggests that tau-induced tubulin 
assembly is a cooperative process. 
Positive cooperation could occur if the binding of tau 
alters the conformation of tubulin so as to promote the 
binding of additional tau. TMAO lessens the amount of tau 
needed for assembly and alters the shape of the curve (Fig. 
2A). It may be that these osmolytes mimic the initial 
binding event of tau. This suggests that tau binding or 
TMAO/betaine cause a tubulin and/or tau conformational 
change and that this change favors tubulin assembly. 
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There are other possible mechanisms, which might 
explain how TMAO works. According to the Bolen's 
solvophobic model of TMAO, polypeptide backbones try to 
avoid contacting TMAO (4, 14). Thus, it may be that TMAO 
drive tau and tubulin together, i.e. increase tau affinity 
for tubulin. Kita proposed that TMAO may also change system 
entropy through affecting water surface tension on proteins 
(15). This entropy model could be used to explain how TMAO 
affects tau-induced tubulin assembly. Perturbation of water 
structure might happen around hydrophobic residues in either 
tau or tubulin. We are currently examining the relationship 
between TMAO, tau and tubulin. 
Prior to this report, only TMAO was suggested to 
stimulate tubulin assembly in cartilaginous fishes (3). No 
molecule is known to have a TMAO-like role on microtubules 
in mammalian cells. We chose betaine to test because of the 
structural similarity of betaine and TMAO. Moreover, 
betaine is a natural metabolite of choline in mammalian 
cells. Betaine actually counteracted the effects of urea 
better than TMAO (Fig. 3). Furthermore, since glycerol and 
glycine were ineffective or in the case of glycine, 
inhibitory to the process of tubulin polymerization, the 
effects of TMAO or betaine can not be described to a simple 
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change in osmotic conditions. Thus, the trimethyl groups of 
TMAO and betaine may act to surround the hydrophobic 
residues of tubulin or tubulin. Since TMAO and betaine are 
amphipathic, these substances may also interact with 
hydrophilic groups or water. Although tau is not found in 
kidney cells, other MAPs, such as MAP2, might play the same 
role as tau does. Regardless of this, our report shows that 
betaine is capable of influencing MT assembly in mammalian 
cells and counteracting substances like urea. 
Finally, it is known that tau loses its binding 
affinity to MT in Alzheimer's disease. In the disease 
state, tau is hyperphosphorylated, which may contribute to 
microtubule disassembly and neuron death (16) . Based on the 
effect of TMAO and betaine on our observations presented in 
this study, it will be important to determine the effect of 
TMAO or betaine on the interaction between phosphorylated 
tau and tubulin. These studies are currently in progress in 
our laboratory. 
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Abstract 
Phosphorylation can affect the function of microtubule-
associated protein tau. Here, the human brain tau with 441 
amino acids was phosphorylated by cyclic-AMP-dependent 
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protein kinase (PKA) or glycogen synthase kinase-3p. PKA-
phosphorylated tau (2.7 mol phosphates/mol) does not promote 
tubulin assembly as judged by spectrophotometric and atomic 
force microscopy measurements, unless trimethylamine N-oxide 
(TMAO), a natural occurring osmolyte, is included in these 
assays. TMAO is also found to promote tubulin assembly of 
glycogen synthase kinase-3P-phosphorylated tau (1.6 mol 
phosphates/mol). TMAO does not act by causing a chemical 
dephosphorylation of phosphorylated tau but it acts to 
overcome the functional deficit caused by phosphorylation. 
PKA-phosphorylated tau binds to tubulin in the presence of 
TMAO and lowers the critical concentration of tubulin needed 
for assembly. From these data we conclude that PKA-
phosphorylated tau retains the ability to bind tubulin and 
promote tubulin assembly. TMAO is required, however, to 
sensitize the reaction. Possible uses of TMAO in relation 
to studies of tubulin assembly in vitro, in intact cells, 
and in relation to Alzheimer's disease are presented in this 
report. 
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Introduction 
Hyperphosphorylation or abnormal phosphorylation of tau 
has been proposed as one potential cause of Alzheimer's 
disease (1-4). It is believed that this 
hyperphosphorylation reduces the affinity of tau for tubulin 
and can contribute the self association of tau and formation 
of neurofibrillary tangles or paired helical filaments (PHF) 
(1-4), major hallmarks of Alzheimer's disease. A recent 
study shows, however, that some phosphorylation reactions of 
tau may protect it against formation of PHFs (5). At least 
25 sites have been identified in the tau of paired helical 
filaments (PHF-tau) (6, 7). These sites can be classified 
as either proline-directed or non-proline-directed 
phosphorylation sites (6, 7). Both types of phosphorylation 
can affect tau's function. For instance, tau phosphorylated 
by either cyclic-AMP-dependent protein kinase (PKA) or 
glycogen synthase kinase-3P (GSK-SP) reduces its ability to 
stimulate the formation of microtubules (MTs) (8, 9). PKA, 
a non-proline-directed kinase, phosphorylates tau on Ser-
214, Ser-262, Ser-316, Ser-320, Ser-356, Ser-409, Ser-416 
and one of residues, Ser-235, Ser-237, or Ser-238 (5-8, 10, 
12). GSK-3p, a proline-directed kinase, phosphorylates tau on 
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Ser- 1 9 9 ,  Thr- 2 3 1 ,  Ser- 2 3 5 ,  Ser- 2 6 2 ,  Ser- 3 9 6 ,  Ser-400, and 
Ser - 4 1 3 ,  most of which are in Ser/Thr-Pro motifs (6, 7, 9 ,  
11). Activation of PKA in SH-SY5Y neuroblastoma cells can 
increase phoshorylation of Ser-262/Ser-356 in tau and cause 
the disassociation of tau from MTs ( 1 3 ). GSK - 3 P  
phosphorylation has been proposed to play a role in 
Alzheimer's disease (14, 15). A previous study showed that 
endogenous tau can be phosphorylated by GSK-3|3 in cultured 
human NT2N neurons (16). 
Tau exists as six isoforms in the human brain and these 
forms are derived from a single gene by different mRNA 
splicing reactions (17-19). The largest brain tau 
containing 441 amino acids possesses two N-terminal inserts 
and four MT-binding repeats, but the smallest form possesses 
no N-terminal insert and has three MT-binding repeats 
instead (17, 18). The tau structure for all isoforms is 
enriched with proline, glycine, and hydrophilic amino acids 
(19). Early biophysical studies of tau using analytical 
centrifugation, electron microscopy, gel filtration, CD, and 
^H-NMR spectroscopy suggest that tau is a highly flexible 
extended molecule with little secondary structure (20-25). 
Recent studies suggest that hyperphosphorylation with 
mitogen-activated protein kinase induced structure into the 
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C-terminal region of tau (23), and that the secondary-
structure of Alzheimer's disease-hyperphosphorylated tau can 
be changed by dephosphorylation (26) . Studies by Hagestedt 
et al. by using paracrystal imaging showed that 
Ca/calmodulin protein kinase II can reduce tau's flexibility 
by phosphorylation (27). In addition, binding of tau to MTs 
can also generate some ordered structures, indicating that 
MTs can induce some conformational changes in tau (25). 
Small molecular weight organic osmolytes found in 
elasmobranchs, e.g., sharks and rays, act to stabilize 
proteins by counteracting the denaturing effect of urea in 
vivo (28-31) . In a recent paper, it was reported that 
trimethylamine N-oxide (TMAO) can force thermodynamically 
unfolded proteins to fold (32). RNase T1 with its disulfide 
bonds reduced and chemically derivatized and staphylococcal 
nuclease mutant protein (T62P) exist as unfolded 
biologically inactive structures (32). However, in the 
presence of TMAO these proteins become folded and 
biologically active. The authors state "The ability of TMAO 
to force thermodynamically unstable proteins to fold 
presents an opportunity for structure determination and 
functional studies of an important emerging class of 
proteins that have little or no structure without the 
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presence of TMAO" ( 3 2 )  . A previous report of ours showed 
that 2 0 0  itiM TMAO, a physiological concentration ( 2 8 ,  2 9 )  ,  
could increase the formation of tau-inducted MTs and 
counteract inhibition of assembly caused by urea (33). On 
the basis of this and of the background information on tau 
suggesting it exists as an unfolded protein, we initiated 
work on the effect of TMAO on tau phosphorylated by either 
PKA or GSK-3P and their interactions with tubulin. The 
results, shown herein, provide evidence that low 
concentrations of TMAO can overcome the functional deficit 
of phosphorylation of tau by PKA or GSK-3p. 
Materials and Methods 
Materials 
The plasmid of the human tau cDNA encoding 441 amino 
acids was provided by K. Iqbal from New York State 
Institutes for Basic Research in Developmental Disabilities, 
Staten Island, New York. PKA and GSK-3p were purchased from 
Sigma; E.coli BL21(DE3) cells from Novagen; and [y-^^PjATP 
from ICN. TMAO was purchased from Sigma, recrystallized 
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from deionized water, dried, and stored in a desiccator at 
room temperature. All other reagents were reagent grade. 
Phosphorylation o£ Tau 
Hioman recombinant tau was purified as described 
previously (33). Pure recombinant tau (20 flM, based on a 
molecular mass of 45.7 kDa) was phosphorylated by kinases in 
the phosphorylation solution (1 mM ATP/10 mM MgCl/1 iiiM EDTA/ 
0.5 |J,g/ml leupeptin/0.7 ^.g/ml pepstatin/1 (ig/ml aprotinin/85 
^ig/ml PMSF/1 |IM microcystin-LR/25 mM HEPES, pH 7.5) . The 
concentrations of kinases in the phosphorylation reactions 
are 0.2 units/)ll PKA for PKA phosphorylation and 0.4 units/|J,l 
GSK-3|3 for GSK-3p phosphorylation. The phosphorylation 
reactions were carried out at 3 0°C and terminated by heating 
the reaction solutions at 95°C for 10 min. The cooled 
phosphorylated tau was centrifuged at 10,000 X g for 10 min 
to remove protein aggregates, and the supernatants were 
ready for use in the MT assembly. Non-phosphorylated tau was 
treated as the same condition as phosphorylated tau, except 
that no ATP was added. To determine the phosphorylation 
stoichiometry, 1 |i.Ci of [y-^^PjATP was included in the 
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phosphorylation mixture. After incubation, a portion of 
reaction mixture was spotted on a ET-31 paper disc, washed 
with trichloroacetic acid, and analyzed by liquid 
scintillation counting (34) . This filter paper assay was 
also used to evaluate dephosphorylation of phosphorylated 
tau by TMAO. 
TubuliD Preparation and Tubulin Assembly 
The preparation of porcine brain tubulin followed a 
method described by Williams and Lee (3 6) except that a SP-
cation exchange column (high-performance SP from Amersham 
Pharmacia) was used rather than a phosphocellulose column 
(33, 36). The elution rate in the chromatography was 0.5 
ml/min. The elution and collection of tubulin were the same 
as described previously (36) . The assembly condition and 
the turbidity measurement were described in a previous paper 
(33). In brief, thawed tubulin was centrifuged at 15,000 X 
g for 10 min, at 4°C to remove tubulin aggregates. This 
supernatant was collected and used for assembly reactions. 
Assembly started with the addition of tubulin (8 |iM, based on 
a molecular mass of 55 kDa) to assembly mixture which 
contained without/with 200 mM TMAO/with/without 0.8 tau/1 
mM GTP/1 mM DTT/1 mM MgClj/l mM EGTA/0.1 mM EDTA/100 mM MES, 
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pH 6.4. The assembly process was monitored by following 
changes in absorbance at 350 nm by using a Beckman (Beckman 
Dickinson) DU640 spectrophotometer. The presence of a small 
amount of ATP from the phosphorylation reaction did not 
affect tubulin assembly. The determination of tubulin-
critical concentrations followed the principle described by 
Timasheff's laboratory (37, 38). The concentrations of tau 
and PKA-phosphorylated tau (2.8 mol phosphates/mo1) were 0.8 
^M. TMAO was 200 mM. The assembly buffer and the turbidity 
measurement were the same as above, except that the 
incubation time was 20 min. At least four different 
concentrations of tubulin were applied in each assembly 
group. A linear curve fitting method was used to obtain a 
line, which fits the data in the same assembly group. The 
x-intercepts of the fitted lines were designated to be the 
tubulin-critical concentrations. 
Analysis of Phosphorylated Tau-Tubulia Complex 
Tau was phosphorylated with PKA in the presence of [y-
^^P]ATP. Phosphorylated tau was incubated with tubulin or 
without tubulin in the assembly buffer containing 200 mM 
TMAO. After 15 min assembly incubation, the pellets were 
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collected by a centrifugation of 50,000 X g for 30 min at 
25°C. The pellets were washed three times with pre-warmed 
(30°C) assembly buffer containing 2 00 mM TMAO. The washed 
pellets were resuspended in 50 fll cold assembly buffer (0-
4°C) and analyzed for radioactivity. 
Atomic Force Microscopy (AFM) 
The assembly mixtures were incubated under the assembly 
condition described above, followed by a fixation with 0.8% 
glutaraldehyde for 3 0 s. Ten microliters of the fixed 
samples was deposited onto a disc with a freshly cleaved 
mica surface and incubated for 5 min, followed by gentle 
rinsing with 1 ml HPLC grade water. The mica discs were 
then dried under a lamp for 5 min, during which time the 
temperature of the mica surface was gradually raised to 45°C. 
After this, sample discs were transferred into a 55°C oven 
with vacuum and incubated for 24 hr. The samples were 
imaged in air with a NanoScope III AFM (Digital Instruments, 
Santa Barbara, CA) by using a Tapping Mode. .. The imaging 
conditions usually were: height and amplitude modes. Ultra 
levers (Park Scientific, Sunnyvale, CA), scanning rate 1.97 
Hz, and < 50% relative humidity. Captured AFM images were 
processed and analyzed using NANOSCOPE software. 
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Micropipette tips used in this AFM experiment were cut off 
to avoid shearing. 
Protein Concentration Determination 
Porcine brain tubulin was dissolved in 6 M guanidine*HCl 
and its absorbance was determined by spectrophotometric 
measurement at 275 nm. The extinction coefficient for 
tubulin in guanidine*HCl at 275 nm is 1.03 ml/mg/ cm (37). 
Tau concentration was measured by the Bradford method (39), 
by using tau solutions with known concentrations as 
standards. 
Results 
Human brain recombinant tau was phosphorylated with PKA 
to an extent of 2.7 + 0.1 mol phosphates/mo1. Using 
conditions that promote tubulin assembly, we found, like 
others (8), that PKA-phosphorylated tau does not promote 
tubulin polymerization as judged by spectrophotometric 
measurements (Fig. la) . However, if 200 iiiM TMAO is included 
in the assembly mixture, turbidity increases and the rate 
and extent of the reaction are equivalent to that seen with 
Figure 1. (a) Spectrophotometric measurement of tubulin 
assembly. Tubulin was incubated {30°C, 15 min) 
alone (solid circles) or with TMAO (solid 
triangles) and the assemblies were monitored by an 
increase in the absorbance at 350 nm. By using 
the same conditions, tubulin was assembled in the 
presence of tau (open circles), or tau and TMAO 
(open triangles). Finally, tubulin was assembled 
with PKA-phosphorylated tau in the presence (open 
squares) or absence (solid squares) of TMAO. The 
phosphorylation stoichiometry of PKA-
phosphorylated tau was 2.7 + 0.1 phosphates/mol. 
(b) SDS/PAGE analysis of tau proteins. Non-
phosphorylated tau (lane 1) and PKA-phosphorylated 
tau with 2.8 phosphates/mol (lane 2) were analyzed 
in a 10% polyacryamide SDS gel. Proteins in the 
gel were visualized by a Coomassie brilliant blue 
R staining. (c) Radioautogram of "P-labeled tau 
in a SDS/PAGE analysis. Tau was phosphorylated 
with PKA in the presence of [Y-^^P]ATP. Any 
aggregates of phosphorylated tau-TMAO (lane 1) and 
phosphorylated tau-tubulin-TMAO (lane 2) were 
collected by centrifugation and analyzed by 
SDS/PAGE gel. 
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non-phosphorylated tau. The upper curve in Fig. la shows 
that stimulatory effect of TMAO by using non-phosphorylated 
tau, and it is similar to what was reported earlier by us 
(33). If the temperature is lowered in an assembly mixture, 
the formed MTs can disassemble (40). We found that the 
change in absorbance caused by the presence of mixtures of 
tau-tubulin or tau-tubulin-TMAO observed at 3 0°C could be 
reversed by altering the temperature to 4°C (results not 
shown). 
SDS/gel electrophoresis profiles of tau and tau 
phosphorylated by PKA are shown in Fig. lb. Non-
phosphorylated tau (lane 1) migrates as a single band, and 
phosphorylated tau (lane 2) migrates slower as expected (8). 
One major band is found for phosphorylated tau. A slower 
moving minor band is found, indicating some heterogeneity in 
the phosphorylated tau preparation. However, no non-
phosphorylated tau is detected by SDS/PAGE analysis. 
Similar results were seen with capillary iso-electric 
focusing electrospray ionization mass spectrometry of PKA-
phosphorylated tau containing 2.6 mol phosphates/mol (12). 
These results strongly suggest that PKA-phosphorylated tau 
induces tubulin polymerization judged by the 
spectrophotometric measurements of Fig. la. Results shown 
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in Fig. la can not be explained by the presence of non-
phosphorylated tau in the PKA.-phosphorylated preparation. 
The possibility existed that TMAO might act to cause a 
dephosphorylation of tau because it has been reported that 
TMAO can act as a nucleophile to remove phosphate from 
phosphorylated y-picoline monoanion (41). To test this 
possibility, we generated ^^P-labeled tau by phosphorylation 
with PKA and incubated phosphorylated tau with 2 00 mM TMAO 
at 3 0°C. After incubation of 60 min, we found no loss of 
radioactivity from phosphorylated tau (data not shown). 
Thus, the effect of TMAO on phosphorylated tau can not be 
explained by a chemical reaction leading to the formation of 
non-phosphorylated tau. 
The spectrophotometric results in Fig.la suggest that 
phosphorylated tau bound to tubulin in the presence of TMAO. 
To test this idea more directly, we incubated tubulin with 
^^P-labeled tau (2.7 + 0.1 mol phosphates/mol) and collected 
the polymerized tubulin by centrifugation (Materials and 
Methods). This fraction contained radioactivity (30.0 
picoCi) but little or no ^^P-labeled tau sedimented in the 
control (0.27 picoCi). An autoradiogram of the SDS/PAGE gel 
of phosphorylated tau and phosphorylated tau-TMAO-tubulin is 
shown in Fig.lc. Only lane 2 shows detectable 
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radioactivity. These results suggest that PKA-
phosphorylated tau associates with tubulin in the presence 
of TMAO, and that TMAO does not promote self aggregation of 
PKA-phosphorylated tau in our assembly conditions. 
The change in absorbance at 350 nm shown in Fig. la is 
characteristic of the formation of MTs (37), but it is not 
clear what exact structures are being formed, particularly 
in the new reactions containing TMAO. To examine the 
morphology of the structures formed in the reaction 
mixtures, we used AFM. First, as expected from the data of 
Fig. 1, tubulin alone (Fig. 2a) and tubulin plus 200 mM TMAO 
(Fig. 2c) do not aggregate. But when tau is added, MTs are 
formed (Fig. 2b and d). Note there are no apparent 
differences in the structures of MTs formed in the absence 
(Fig. 2b) and presence (Fig. 2d) of TMAO. Thus, at 200 mM, 
TMAO has no adverse effect on the morphology of MTs. Under 
these conditions, the MTs are generally straight and are 
several-micrometers long (Fig. 2b, d, and f). In contrast, 
those formed by using phosphorylated tau (Fig. 2f) tend to 
be shorter. As expected from the spectrophotometric studies, 
PKA-phosphorylated tau (2.7 + 0.1 mol phosphate/mol) plus 
tubulin does not make any MTs (Fig. 2e) unless 200 mM TMAO 
is present (Fig. 2f). The heights of all MTs in Fig. 2b, d. 
Figure 2. AFM images of tubulin assembly. Tubulin (a) was assembled using standard 
reaction conditions (Figure 1), and fixed. The mixture was then spotted 
onto a mica disc, dried and scanned by AFM. Other reaction mixtures that 
included tau (b), TMAO (c), tau + TMAO (d), PKA-phosphorylated tau with 
2.7 phosphates/mole (e), or PKA-phosphorylated tau + TMAO (f) were also 
scanned. The sample height is color coded as indicated by the height 
scale bar. Note field sizes for a, c, and e (2 X 2 pm) are smaller than 
those for b, d, and f (25 |im X 25 |im) in order to highlight features. The 
heights of MTs shown in b, d and f are all about 20 nm, in general. 
2 
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and f are all about 20 + 5 run. The widths of all MTs shown 
above are about the same. Because of the association of ^^P-
labeled tau with tubulin in the presence of TMAO, we 
conclude that the polymerized MTs shown in Fig. 2f are 
caused by the combination of phosphorylated tau with 
tubulin. 
To learn how TMAO affects MT assembly, we determined 
the critical concentration of tubulin needed for assembly 
(Fig. 3). The critical concentration of tubulin required for 
tubulin self assembly is about 0.8 mg/ml (Fig. 3) similar to 
what were reported previously (37, 38, 42). TMAO (200 mM) 
lowers the critical concentration of tubulin to about 0.4 
mg/ml (Fig. 3), whereas that in the presence of tau is 0.1 
mg/ml or TMAO plus tau is about 0.03 mg/ml (Fig. 3). Note 
that when PKA-phosphorylated tau is used there is no change 
in the critical concentration of tubulin (0.79 mg/ml), but 
when TMAO is added the critical concentration drops to a 
value of about 0.25 mg/ml (Fig. 3). This value is 
significantly lower than that found with TMAO and tubulin. 
Thus, TMAO not only lowers the concentration of tubulin 
needed for assembly but also sensitizes the assembly process 
to tau and phosphorylated tau, which was completely 
ineffective under these experimental conditions. 
Figure 3. The determination of tubulin-critical 
concentrations. Six assembly groups were analyzed: 
(i) tubulin alone (open circles) ; (ii) tubulin 
plus TMAO (close circles); (iii) tubulin plus tau 
(open triangles); (iv) tubulin, tau, plus TMAO 
(closed triangles); (v) tubulin plus 
phosphorylated tau (open squares); (vi) tubulin, 
phosphorylated tau, plus TMAO (closed squares). 
The detailed assembly conditions are described in 
Materials and Methods. The lines are the results 
after a linear curve fitting processing for each 
group. 
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Phosphorylation of GSK-SP is known to affect tau 
function (9, 11, 16). In contrast to PKA, GSK-3Phas a 
substrate preference with the sequence for Ser/Thr-Pro, 
which characterizes a "proline-directed" kinase (6). To 
examine whether TMAO can affect tubulin polymerization with 
proline-directed phosphorylated tau, we generated GSK-
3P-phosphorylated tau and tested it with TMAO. As shown in 
Fig. 4a, the assembly of MTs caused by 0.8 |HM GSK-3P-
phosphorylated tau (1.6 mol phosphates/mol) was 
significantly decreased compared to non-phosphorylated tau. 
However, tubulin assembly with this phosphorylated tau could 
be promoted by the addition of 2 00 mM TMAO to an extent seen 
with non-phosphorylated tau (Fig. 4a). SDS gel 
electrophoresis of GSK-SP-phosphorylated tau (1.6 mol 
phosphates/mol) shows two major bands which migrate slower 
than the control non-phosphorylated tau. A small amount of 
non-phosphorylated tau (approximately 10%) may be present in 
the GSK-3P-phosphorylated sample (results not shown). On this 
basis and from our earlier results of the amount of non-
phosphorylated tau needed for assembly (33), we conclude 
Figure 4. Analysis of tubulin assembly with GSK-SP-
phosphorylated tau. (a) Spectrophotometric 
measurement of tubulin assembly. Reaction 
mixtures contained tubulin alone (solid circles) 
or tubulin + (solid triangles) . Other 
reactions contained tubulin in the presence of tau 
(open circles), tau + TMAO (open triangles), GSK-
3P-phosphorylated tau (solid squares) or GSK-3p-
phosphorylated tau + TMAO (open squares). The 
phosphorylation stoichiometry of GSK -3P-
phosphorylated tau is 1.6 phosphates/mol. (b) AFM 
image of the reaction mixture that contained 
tubulin, GSK-SP-phosphorylated tau and TMAO. 
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that the results of Fig. 4a can only be explained by the 
participation of GSK-3P-phosphorylated tau in the tubulin 
assembly. To correlate these data with a physical 
structure, we used AFM to observe the final products in 
assembly mixture. Again, it was found, as with PKA-
phosphorylated tau, that MTs are assembled in the co-
presence of GSK-3p-phosphorylated tau and TMAO (Fig. 4b). 
These results show that TMAO can also restore GSK-3P-
phosphorylated tau-MT assembly. 
Discussion 
It is thought that in Alzheimer's disease abnormal 
phosphorylation of tau causes tau to lose its ability to 
promote tubulin assembly. This functional deficit can be 
overcome by enzymatic dephosphorylation in vitro (1-4, 43). 
Yet, how might the consecjuence of abnormal phosphorylation 
be overcome in the brain in Alzheimer's disease? Much 
research is being done to study which specific protein 
phosphorylations-dephosphorylations occur and how they are 
regulated in the diseased state. In this paper, we report 
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new findings suggesting that a small organic osmolyte TMAO 
can overcome the functional deficit of tau caused by 
specific enzymatic phosphorylation reactions. Because no 
dephosphorylation occurs, the effect of TMAO is unlike that 
caused by phosphatases acting on tau. 
How might TMAO work to overcome the functional deficit 
of tau caused by phosphorylation? We found that in the 
presence of 2 00 mM TMAO, PKA-phosphorylated tau binds to 
tubulin and promotes formation of MTs (Fig. 1). TMAO can 
lower the critical concentration of tubulin, and the 
addition of PKA-phosphorylated tau lowers the concentration 
further (Fig. 3). No effect on critical concentration of 
tubulin is seen with PKA-phosphorylated tau in the absence 
of TMAO, suggesting that PKA-phosphorylated tau has little 
or no effect by itself on tubulin assembly. Studies done by 
Lee and Timasheff (38) showed that observed critical 
concentration of tubulin required for assembly is a 
thermodynamic indicator of assembly; the lower the critical 
concentration the more negative is the apparent free energy 
for assembly (38, 42). On this basis, a lower apparent free 
energy for the assembly could be expected in the presence of 
TMAO, PKA-phosphorylated tau, and tubulin, compared to that 
observed for TMAO and tubulin. 
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Extensive studies from Timasheff's laboratory showed 
that osmolytes like TMAO stabilize proteins by causing a 
preferential hydration of the proteins (44-47). TMAO has 
been found to raise the free energy of the unfolded state of 
proteins and to promote folding by a "solvophobic" effect on 
proteins (32, 47). In the presence of a cosolvent with 
solvophobic properties, water is preferred to surround the 
protein surface and the cosolvent is excluded (46). Release 
of bound water molecules occurring during folding or in 
specific association reactions (46, 47) contributes to the 
favorable energetics. The release of bound water was found 
in tubulin assembly (39) and may explain how TMAO can lower 
the critical concentration of tubulin for tubulin self 
assembly, as well as for tau-tubulin assembly. 
How can TMAO change the properties of phosphorylated 
tau? Studies from Urry's laboratory suggest that covalently 
bound phosphate in elastin polypeptides can influence a 
conformational transition and change local interactions by 
influencing hydration (48, 49). Phosphate groups tend to 
prevent the formation of more ordered water structure around 
hydrophobic moieties (48). Possibly, TMAO, by influencing 
hydration, could alter key contacts needed for the 
association of phosphorylated tau with tubulin. 
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We found the concentration of TMAO needed for assembly 
is far less than that required to promote folding of 
unfolded proteins. Chemically derivatized RNase and a 
staphylococcal nuclease mutant, both of which are unfolded, 
requires 2-3 M concentrations of TMAO to restore structure 
and function of these proteins. An earlier study showed 
that molar concentration of TMAO affected tubulin assembly 
(35). In this work, we found that TMAO can act at lower 
concentrations (200 mM) on tau. However, TMAO at this 
concentration has no effect on the CD spectrum of tau (33). 
One possibility is that the requirement for the amount of 
TMAO needed to induce structure may be lower for proteins 
that associate with each other if one protein serves as a 
folding template for the other. Because tau and its 
phosphorylated forms are thought to be highly extended 
molecules with little secondary structures, tubulin may 
alter tau's flexibility. ^H-NMR studies suggest that the 
flexibility of tau can be changed, as shown by the fact that 
half of the methyl-containing residues of tau become 
immobilized upon tau binding to tubulin (25) . Therefore, 
specific binding of tau with tubulin may explain why 200 mM 
TMAO is so effective in promoting tau-tubulin assembly. 
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The fact that concentrations of TMAO found in living 
tissues can affect tubulin assembly in vitro suggests there 
may be some application for studies of effects of TMAO on 
tubulin assembly in cells. Experiments with the XRl glial-
like cell line, isolated from Xenopus retinal 
neuroepithelium, show that the amounts of cellular MTs are 
increased by adding TMAO into medium, but that they return 
to the basal level by removing TMAO (H.-C.T., D.S. 
Sakaguchi, D.B. Fulton, and D.J.G., unpublished work). 
Last, both PKA-phosphorylated tau (Figs.la and 2) and 
GSK-3p-phosphorylated tau (Fig. 4) can promote MT formation 
in the presence of TMAO and the appearances of the MTs 
formed in both cases are similar. Because GSK-3P is known to 
phosphorylate different sites than PKA in tau (6, 7), our 
results suggest that the effects of TMAO are not related 
just to one specific type of phosphorylation. Studies are 
in progress to define the different sites of phosphorylation 
with PKA and GSK-3(S. Preliminary mass spectrometry studies 
show that Ser-214 and Ser-356 are major sites of 
phosphorylation in PKA-phosphorylated tau containing 2.6 
moles of phosphate/mol (12). Overall, our studies suggest 
that TMAO may be used as a tool to study microtubule-
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associated protein-induced MT assembly and MT disassembly in 
relation to neurodegenerative disease, such as Alzheimer's 
disease, which may be caused in part by tau phosphorylation. 
Footnotes 
Abbreviations: MT, microtubule; PKA, cyclic-AMP-
dependent protein kinase; GSK-3P, glycogen synthase kinase-
3P; AFM, atomic force microscopy; TMAO, trimethylamine N-
oxide. 
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CHAPTER 4 
THE METHYLAMINE OSMOLYTE, TRIMETHYLAMINE N-OXIDE, 
PROMOTES TUBULE ASSEMBLY IN XRl GLIAL CELLS 
A paper to be submitted to the Journal of Cell Biology 
Huang-Chun Tseng, Donald S. Sakaguchi, D. Bruce Fulton,^ 
and Donald J. Graves^'^ 
^Neuroscience Program, ^Department of Biochemistry, 
Biophysics, and Molecular Biology, and ^Department of Zoology 
and Genetics, Iowa State University, Ames, Iowa 50011, 
U.S.A. 
Abstract 
Methylamine osmolytes are enriched in urea-rich cells 
and can promote microtubule assembly in vitro (1). It is 
unclear, however, whether methylamines can promote 
microtubule assembly in cells. We tested trimethylamine N-
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oxide (TMAO), a methylamine osmolyte, and examined its 
effects on the microtubule assembly of the XRl glial cell 
line, using immunocytochemistry. The results of 
immunofluorescent staining showed that an increase in 
microtubule assembly occurred when culture media contained 
20 0 mM TMAO, and this increase in assembly could be reversed 
by removal of TMAO from media. The increase in tubulin 
assembly is not caused by an increase in the biosynthesis of 
tubulin as shown by an immunoblotting assay. The change of 
microtubule assembly was correlated with the concentrations 
of intracellular TMAO, analyzed by ^H-NMR spectroscopy. The 
intracellular concentration of TMAO reached 30-50 mM after 
6-hour incubation with 200 mM TMAO. During this time period 
microtubule assembly increased significantly. A 
spectrophotometric assay for microtubule assembly in vitro 
showed that 50 mM TMAO affected microtubule assembly, 
supporting the observations in cells. TMAO did not affect 
F-actin fibers as judged by fluorescent staining with 
rhodamine-phalloidin. Glycerol, another organic osmolyte, 
did not increase microtubule assembly of XRl cells. These 
results indicate that the methylamine osmolytes, such as 
TMAO, can specifically enhance microtubule assembly in 
cells. 
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Introduction 
Cells accTomulate organic osmolytes to maintain 
intracellular osmotic balance in hypertonic environments. 
Three types of organic osmolytes are known to be accumulated 
by cells: polyols (such as glycerol), amino acids and amino 
acid derivatives, and methylamines (2). The first two types 
of osmolytes are called compatible osmolytes because high 
concentrations of these osmolytes do not alter proteins' 
functions (2, 3). Methylamine osmolytes can counteract the 
denaturation effect of urea on proteins and, therefore, are 
also called counteracting osmolytes (2-4) . 
Methylamine osmolytes are commonly found in many urea-
rich tissues, such as the muscle of elasmobranchs (2, 4), 
coelacanth (2, 4), moridase (5), macrouridae (5), and the 
mammalian kidney (6). The concentrations of urea and 
methylamines form an approximately 2:1 ratio in many marine 
animals (2, 4). In elasmobranchs, the concentration of 
trimethylamine N-oxide (TMAO), a methylamine osmolyte, can 
be as high as 2 00 mM in which the concentration of urea is 
approximately 400 mM (2, 4). Several enzymatic kinetics 
studies have shown that when urea and TMAO are present in a 
2:1 ratio, TMAO can offset the urea protein perturbations on 
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creatine kinase, pyruvate kinase, argininosuccinate lyase, 
and lactic dehydrogenase (4). TMAO has been reported to 
behave as a chemical chaperon (3). TMAO can force 
chemically modified RNase and mutant RNase, two inactive, 
unfolded proteins, .to fold and to become active (7). 
Microtubules are cytoskeletal structures that are 
formed by polymerizing tubulin dimers and microtubule-
associated proteins (MAPs) (8). The assembly-disassembly of 
microtubules is sensitive to many factors, including the 
concentration of tubulin, temperature, pH, ions (9), 
hydrostatic pressure (10), mitotic poisons (such as 
colchicine) (11), and MAPs (8). Microtubule assembly is 
inhibited by urea both, in vitro (12) and in vivo (13). How 
urea-rich cells protect their microtubules from the 
deleterious effects caused by urea is not yet clear. 
One earlier study shows that the osmolyte TMAO can 
uniquely promote tubulin assembly in vitro (14) . 
Paclitaxel-stabilized tubulin assembly is inhibited by 
glycine, sarcosine, taurine, glycylcycine, trimethylejnine, 
or betaine (14). Betaine is a methylamine osmolyte widely 
found in mammalian cells, such as renal cells (6). It is 
presently unknown how renal cells maintain microtubule 
structure under the condition of high urea and high 
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osmolytes but in the absence of TMAO. A recent report 
showed that TMAO and betaine exhibit a similar enhancement 
on the assembly of MAP tau-tubulin and counteract the 
inhibition of urea in vitro (1). That enhancement of tau-
tubulin assembly occurs in the presence of 200 mM TMAO or 
betaine without any microtubule-stabilizing drug (1). These 
results suggest that MAPS play important roles on 
methylamine-enhanced microtubule assembly. MAPs are 
ubiquitous in cells. On these bases, we hypothesize that 
methylamine osmolytes, such as TMAO, at physiological 
concentration could promote microtubule assembly in cells. 
In the present report we confirm this hypothesis with 
observations in intact cells. 
For these studies we chose the XRl cell line. These 
cells were originally isolated from Xenopus retinal 
neuroepithelium (15). XRl cells are glial in nature based 
on their immunoreactivities with antibodies directed against 
glial fibrillary acidic protein and vimentin, two glial cell 
markers (15). XRl cells also promote neurite outgrowth from 
embryonic retinal explants (15). The microtubules and F-
actin of XRl cells were analyzed by immunocytochemistry and 
fluorescent phalloidin staining, respectively. The 
intracellular TMAO concentration was determined by ^H-NMR 
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spectroscopy. The specificity and the mechanism of the 
TMAO-induced assembly reaction are examined in this report. 
Materials and Methods 
Media and Solutions 
XRl cells were cultured in a control medium composed of 
60% L15 medium supplemented with 10% fetal bovine serum and 
Xenopus embryo extract [L15 media purchased from Sigma, MO; 
fetal bovine servim. Upstate Biotechnology Inc., NY; the 
preparation of embryo extract, (15)]. Phosphate-buffered 
saline (PBS) was comprised of 136 mM NaCl, 2.68 mM KCl, 10.4 
mM NajPO^, and 1.76 mM KH2PO4, at pH 7.4. Phosphate buffer 
(PB) was made of 0.1 M sodium phosphate, pH 7.4. Blocking 
solution was made of 5 % goat serum (Sigma, MO), 0.4 % 
bovine serum albumin (Sigma, MO) and 0.2 % Triton X-100 
(Fisher Scientific, NH) in PBS. Hank's dissociation solution 
was made of 5.37 mM KCl, 0.44 mM KH2PO4, 10.4 mM NazHPO^, 
137.9 mM NaCl, 9.0 mM D-glucose, and 0.04 mM Phenol Red in 
Sigma double-processed tissue culture water, pH 7.4, 
supplemented with 2% fungibact (Sigma, MO), 1 % 
penicillin/streptomycin (Sigma, MO), 526 mM EDTA (Fisher 
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Scientific, NH) and 0.05% trypsin (Sigma, MO), pH 7.4. TMAO 
(Sigma, MO) was recrystallized in deionized water, dried, 
and stored in a dessicator. TMAO stock solution was 
dissolved in a 60% L15 solution and sterilized by filtration 
with a 0.22 )iiii membrane (Fisher Scientific, NH) . The 
glycerol stock solution was prepared by dissolving glycerol 
(Fisher Scientific, NH) in 60% L15 media followed by a 
membrane filtration. Glycine (Sigma, MO) and NaCl stock 
solutions were prepared similarly. All osmolyte stock 
solutions were freshly prepared immediately before 
experiments and the pHs were adjusted to 7.4 with diluted 
NaOH or HCl. The buffer used in nuclear magnetic resonance 
(NMR) spectroscopic measurement was made of 100 mM KCl, 30 
mM NaCl, 5 mM NaHzPO^/NajHPO^, and 1 mM MgSO^ to mimic the cell 
cytosol (15). 
Cell Culture 
The XRl cell line was cultured in the control culture 
medium at room temperature in air. The XRl cells were 
seeded onto 12-mm glass coverslips (Fisher Scientific, NH) 
prior to the experiments. To seed XRl cells, subconfluent 
XRl cells were detached from culture flasks by incubating in 
dissociation solution for 10 min at room temperature with 
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gentle shaking. Detached cells were collected by 
centrifugation (1,000 X g for 10 min) and resuspended in 
control culture media. The XRl cells were seeded onto acid-
washed glass coverslips coated with ECL (Upstate 
Biotechnology Inc., NY) at a concentration of 10 p,g/ml. 
Experiments used confluent XRl cells. The XRl cell 
coverslips were transferred into control media or 
experimental media containing TMAO, glycerol, or NaCl to 
start the experiments. Incubations were carried out at room 
temperature in air. 
Immunocytochemistry 
After experimental treatments (as described in text and 
legends), XRl cells were fixed with 4% paraformaldehyde 
(Fisher Scientific, NH) in PB for at least 20 min, followed 
by three 10-min washes with PBS. The fixed cells were 
subsequently incubated in blocking solution for 3 0 min. 
Microtubule cytoskeletons of XRl cells were labeled 
using E7, a monoclonal antibody directed against P-tubulin 
(Developmental Studies Hybridoma Bank, Univ. of Iowa, Iowa 
City, lA) overnight at 4°C. The working concentration of E7 
was at a dilution ratio of 1:20, diluted in blocking 
solution. The labeling of tubulin primary antibodies was 
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visualized by the application of Alexa 488-conjugated goat-
anti-mouse secondary antibodies (Molecular Probes, OR). The 
Alexa 488-conjugated secondary antibodies were diluted in 
blocking solution at a dilution ratio of 1:200. Finally, 
the actin cytoskeleton was visualized in cells previously 
labeled with the anti-^-tubulin antibody using rhodamine-
conjugated phalloidin (1:400, Molecular Probes, OR) for 2 0 
min, in the dark. Cells were then rinsed extensively in 
PBS. Stained cells were mounted onto microscope slides with 
Vectashield (Vector Labs, CA) and visualized by fluorescence 
microscopy. 
Microscopy and Digital Imaging System 
Fluorescent staining patterns in XRl cells were 
visualized with a Nikon Microphot FXA (Nikon, Japan) using a 
IGX subjective, a 20X air objective, or a 40X oil immersion 
objective. Images were captured with a Kodak Megaplus 1.4 
CCD camera (Kodak Corp., CA) connected to a Perceptics 
MegaGrabber framegrabber (Perceptics Corp., TN) in a 
Macintosh 8100/80 AV computer (Apple Computer, Cupertino, 
CA) with NIH Image 1.58VDM software (Wayne Rasband, National 
Institutes of Health, Bethesda, MD; obtained at FTP site 
zippy.niinh.nih.gov) . To hinder subjectivity in the 
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interpretation of fluorescent images, four samples were 
processed at each condition in blind experiments (i.e., the 
experimenter did not know the condition when examining the 
sample and taking pictures). Image enhancement was 
performed on a Macintosh PowerPC 7300/200 (Apple Computer 
Co., CA) using Adobe Photoshop 4.0 (Adobe Systems Inc., CA) . 
The images were printed on photo paper in 1,440 X 720 dot 
per inch (dpi) resolution using an SP700 printer (Epson 
America, Inc., CA) for this publication. 
NMR Spectroscopy 
XRl cells with different TMAO treatments were washed 
twice with 5 ml of the control media and detached from the 
culture flask in 10 ml of the dissociation solution. Cell 
pellets were collected by centrifugation of 1,000 X g for 10 
min. Cells were resuspended and homogenized in the NMR 
buffer solution. Centrifugation of 20,000 X g for 10 min 
was used to separate the cytosol (the supernatant) and the 
membrane fraction (the pellet). 
All ^H-NMR spectra were recorded on a Bruker DRX500 
spectrometer (Bruker Instrument, MA) operating at 499.865 
MHz and equipped with a 5-mm TXI probehead. All 
spectra, including those of whole cells, were recorded of 
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0.4 ml samples in an aqueous buffer (see Media and 
Solutions) with 10% added D2O (for the deuteriiim lock 
channel) in standard 5-inm NMR tubes (Wilmad Glass, NJ) . 
External 2,2-dimethyl-2-silapentane-5-sulfonic acid 
(DSS)(Sigma, MO) was used as the chemical shift reference. 
Spectra were recorded at 25° C using the spectrometer's 
temperature control unit. The solvent signal was suppressed 
by setting the RF frequency on resonance with water and 
employing a 40-Hz presaturation pulse during each relaxation 
delay. The acquisition parameters were sweep-width = 6000 
Hz, scans = 16, relaxation delay = 2 s, excitation pulse-
width = 12 microsec, and FID size = 8192 complex points. 
The processing parameters were exponential line broadening = 
2 Hz and final spectrum size = 16384 real points. 
The concentration of cytosolic TMAO was determined by 
quantitative ^H-NMR. A cytosol sample was prepared from a 
fixed number of cells that were treated with 200 mM TMAO for 
6 hours. NMR measurements were performed using a 5-mm 
sample tube fitted with a stem coaxial insert (Wilmad Glass, 
NJ) containing 5 mM 2,2-dimethyl-2-silapentane-5-sulfonate 
(DSS) in D2O that served as an external intensity reference. 
Spectra were collected from the cell sample and a 10-mM TMAO 
standard solution under identical conditions. In each case 
the integral of the TMAO methyl signal was normalized to the 
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integral of the DSS methyl signal. The total cytosolic TMAO 
concentration was calculated from the ratio of the 
normalized TMAO integrals. The cell voliame fraction in the 
NMR sample was estimated from the volume increase (20 ^.1) 
observed after the addition of buffer solution (400 jil) to 
the cell pellet. The intracellular TMAO concentration was 
estimated by dividing the total cytosolic TMAO concentration 
by the cell fraction. 
In Vitro Tubulin Assewbly 
The expression and preparation of the recombinant human 
tau were described in a previous study (1). The preparation 
of porcine brain tubulin followed a method described by 
Williams and Lee (17) except that an SP-cation exchange 
column (high performance SP from Amersham Pharmacia) was 
used rather than a phosphocellulose column (1). The elution 
and collection of tubulin were the same as described 
previously (18). The assembly condition and the turbidity 
measurement were described in a previous paper (1). In 
brief, thawed tubulin was centrifuged at 15,000 X g for 10 
min, at 4°C, to remove tubulin aggregates. This supernatant 
was collected and used for assembly reactions. Assembly was 
initiated by the addition of tubulin (8 |iM, based on a 
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molecular weight of 55 kDa) to the assembly mixture 
without/with TMAO (50 mM, 100 mM, or 200 mM), with/without 
0.8 |XM tau (based on a molecular weight of 45.7 kDa), 1 mM 
GTP, 1 mM DTT, 1 mM MgClz, 1 mM EGTA, 0.1 mM EDTA, and 100 mM 
MES, pH 6.4. The assembly process was monitored by 
following changes in absorbance at 3 50 nm using a Beckman 
DU640 spectrophotometer (Beckman Instruments, Inc., CA). 
Immunoblot and Desitometric Analysis 
XRl cells were homogenized and sonicated in NMR buffer 
solution at 4°C. The homogenates with 2 0 |j,g proteins were 
mixed with SDS-loading buffer, heated under 95-100°C for 5 
min and loaded onto a 10% polyacrylamine SDS-PAGE gel. The 
resolved proteins were electroblotted onto a polyvinylidene 
difluoride (PVDF)(Bio-Rad, CA) membrane. The PVDF membrane 
was immunoblotted with the E7 monoclonal antibody directed 
against Xenopus P-tubulin, followed by incubation with 
horseradish peroxidase-conjugated anti-mouse antibodies and 
visualized using the Immun-Blot assay kit (Bio-Rad, CA). 
The color-developed PVDF membrane was dried and scanned by a 
GS-670 imaging densitometer (Bio-Rad, CA). The scanned 
images were analyzed by the Molecular Analyst version 1 
(Bio-Rad, CA) software package. 
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Results 
Microtubule Assembly in XRl Cells Is Increased by Bath 
Application of TMAO 
The XRl glial cells were grown in TMAO-containing media 
to examine the effects of TMAO on microtubule assembly. XRl 
cells were incubated in 100 mM or 200 itiM TMAO prepared in 
culture media for 1, 3, or 6 hours. Cellular microtubules 
of XRl cells were analyzed using immunocytochemical 
procedures with anti-P-tubulin antibodies followed by Alexa 
488-conjugated secondary antibodies. The tubulin-labeling 
images are shown in Fig. 1. The visualized images are 
microtubule structures. 
We found that the immunofluorescent intensities were 
stronger if cells were incubated in TMAO-containing media 
(Fig. la-c and le-g) compared with those in control cells 
(Fig. li-k). At the same incubation time, the relative 
intensities increased with an increase of TMAO in the media 
(Fig. 1). We interpret this intensity increase in tubulin 
immunofluorescence as evidence of more microtubules in the 
cells. The increase of microtubule assembly appeared not 
only in the microtubule-organizing centers in cells but also 
in other subcellular locations (Fig. Ic, g, and k). 
Figure 1. Iinmunofluorescent analysis of microtubules in XRl 
cells. Cells in Fig. la-d were treated with 200 
itiM TMAO media; cells in Fig. le-h, 100 mM TMAO 
media; cells in Fig. li-1, control media. Cells 
in a, e, and i were incubated for 1 hour in TMAO 
before fixation; cells in b, f, and j, 3-hour 
incubation; cells in c, g, and k, 6-hour 
incubation. Cells in d, h and 1 had 6-hour 
incubation with TMAO or control media and were 
removed to fresh control media for an additional 
18-hour incubation in the absence of TMAO. 
Calibration bar, 50 ^m. 
200 mM TMAO 100 mM TMAO 
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Furthermore, increasing the incubation time in TMAO resulted 
in an increase in the relative tubulin immunofluorescent 
staining (Fig. la-c and le-g). The formed microtubules 
increased up to 6 hours, which was the longest incubation 
time in this study. If TMAO-treated cells were moved to a 
control culture medium (containing no TMAO) and incubated 
for another 18 hours, the labeling intensities (Fig. Id and 
h) decreased to a basal level (Fig. 11). But, the cells in 
Fig. Id still had a stronger immunofluorescent staining than 
did the control cells (Fig. 11). Usually, the 
immunofluorescent staining for cells under the conditions of 
Fig. Ih was the same as that in Fig. 11. The apparently 
strong staining is due to more cells in Fig. Ih. These 
results show that TMAO treatment is able to promote cellular 
microtubule assembly in XRl cells. 
During treatments with TMAO, we did not find any change 
in the cell growth rate or notable cell death. TMAO-treated 
cells (Fig. If) continued to perform cell division at the 
same rate as control cells. In addition, there was no 
obvious change in cell volume for TMAO-treated cells. 
Occasionally, smaller cells were found in TMAO-treated 
cultures. However, a difference in cell size under 
hypertonic solution is expected. With 400 mM TMAO in the 
92 
culture medium we found that most cells had shrunk and 
detached from the substrate (data not shown). 
Intracellular TMAO Determination 
As 200 mM TMAO was able to stimulate microtubule-
associated protein-microtubule assembly in vitro (1), it was 
hypothesized that the increase of microtubule assembly shown 
in Fig. 1 may be due to the presence of TMAO within XRl 
cells. To analyze for TMAO, we used ^H-NMR spectroscopy to 
detect the methyl group signal of TMAO. The cytosol 
fractions isolated from cells in Fig. la, c, d, and k were 
analyzed. But the medium in the cells in Fig. Ik, or the 
control cells, was replaced with a 200 mM TMAO medium and 
was incubated for one min before being harvested. The 
purpose of this one-min TMAO treatment for control cells was 
to rule out the possibility of TAMO contamination in the 
cytosol fraction during sample preparation. 
We found that the proton signal of the methyl group in 
TMAO appeared in the cytosol sample prepared from TMAO-
treated cells (Fig. 2a, b, and c), based on the methyl 
proton chemical shift in the TMAO reference (Fig. 2e). The 
TMAO signals in Fig. 2a, b, and c can not be attributed to 
contamination because the control cells with one-min TMAO 
Figure 2. ^H-NMR spectra of the cytosol fractions of XRl 
cells. The cytosol fractions were isolated from 
XRl cells with or without 200 inM TMAO treatment. 
The collected cells were homogenized in an NMR 
buffer with pH 7.4. After centrifugation, the 
cytosol fractions were analyzed using ^H-NMR 
spectroscopy (see Materials and Methods for 
details). a. The spectrum of the cytosol sample 
of XRl cells treated with 200 mM TMAO for 1 hour; 
b. 6 hours; c. XRl cells incubated in fresh 
control medium subsequent to TMAO treatment (200 
mM TMAO, 6 hours) ; d. the spectriim of the cytosol 
fraction from control cells (see text for the 
detail treatment); e. the reference spectrum of 
TMAO in an NMR buffer, pH 7.4; f. a reference 
spectrum of trimethylamine in an NMR buffer. 
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treatment did not have the TMAO signal (Fig. 2d). The TMAO 
signal was the strongest peak in the spectra a, b, and c, 
except for water (whole spectra not shown). The 
intracellular TMAO did not convert to trimethylamine for 
which the methyl proton chemical shift is 2.93 ppm (Fig. 
2f). Some weak proton signals around 1.5 ppm are due to 
other intracellular compounds. The nearly identical 
strengths of those signals indicate that the cytosol samples 
(Fig. 2a, b, c, and d) were prepared from a similar number 
of cells. Therefore, changes in the signals seen for TMAO 
reflect changes in the concentration of TMAO in cells but 
not differences in the number of cells. The membrane 
fractions of TMAO-treated cells (6 hours) have only a very 
weak signal at 3.3 ppm (data not shown). That weak signal 
may be explained as TMAO in membrane, TMAO contamination, or 
other compounds. Therefore, we conclude that the observed 
TMAO was predominately present inside of the XRl cells. 
The intensity of the TMAO methyl signal in Fig. 2b is 
stronger than that in Fig. 2a. The increase in TMAO signal 
intensity indicates that the intracellular TMAO 
concentration increased with time. Meanwhile, the labeling 
intensity for tubulin in Fig. Ic was stronger than that in 
Fig. la. When examining the cytosol sample prepared from 
96 
cells shown in Fig. Id, we found that there was a TMAO peak 
in the spectriim (Fig. 2c) . These results suggest that the 
increase of cellular microtubules is related to the 
concentration of TMAO. The observation that microtubules in 
Fig. Id did not return fully to the basal level can be 
explained by the residual TMAO in cells. 
The intracellular TMAO concentration of the cells in 
Fig. Ic was also determined by ^H-NMR spectroscopy (see 
Materials and Methods section). We used 5-mM DSS as an 
external reference, which was held in a coaxial insert tube. 
The DSS coaxial insert tube was inserted into an NMR tube 
containing either the cytosol sample or a 10-mM TMAO 
standard. The integrals of cytosolic TMAO, TMAO reference, 
and DSS reference in NMR spectra (data not shown) were used 
to estimate the intracellular TMAO concentration. The 
integral ratio of the TMAO standard to DSS is 26.35. The 
integral ratio of the cytosol TMAO to DSS is 4.251. 
Therefore, the concentration of the cytosol TMAO NMR sample 
is 1.6 mM. That is, the preparation of the cytosol NMR 
sample recovered 0.68 [imoles of TMAO from 2 X 10® cells. We 
estimate that the intracellular TMAO concentration is 
approximately 3 0-50 mM, based on the amount of recovered 
TMAO and the wet cell volume for 2 x 10® cells (see Materials 
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and Methods section). The rate of increase of intracellular 
TMAO was estimated as 5-8 itiM/hour. The rate of removal of 
intracellular TMAO was approximately 0.5-0.8 mM/hour. 
Concentrations of TMAO Influences the Microtubule Assembly 
Because the TMAO concentration and the increase of 
microtubule assembly were correlated in vivo (Figs. 1 and 
2), TMAO concentrations should also affect microtubule 
assembly in vitro. We applied different amounts of TMAO 
into an in vitro assembly mixture containing purified 
porcine brain tubulin and expressed human tau. The 
microtubule assemblies were monitored by spectrophotometric 
measurements, shown in Fig. 3. 
The polymerization of tubulin and tau was monitored by 
the increase of O.D. at 350 run (Fig. 3). In our assembly 
conditions, tubulin alone and tubulin plus 200 mM TMAO did 
not polymerize unless tau was present (Fig. 3). When the 
tau-tubulin mixture included 50 mM TMAO, microtubule 
assembly increased (Fig. 3). With TMAO in the assembly 
mixture, more microtubules were formed (Fig. 3). That is, 
the TMAO concentrations affected the increase of tau-tubulin 
assembly in vitro. This result verifies that TMAO 
concentration and microtubule increase are related and 
Figure 3. Spectrophotometric measurement of tubulin 
assembly. Tubulin was incubated (3 0°C, 15 min) 
alone (open circles) , or with 200 itiM TMAO (open 
squares) or with tau (closed squares) and the 
assemblies were monitored by an increase in the 
absorbance at 350 nm. Using the same conditions, 
tubulin plus tau were assembled in the presence of 
50 mM TMAO (crosses), 100 mM TMAO (closed 
triangles), or 200 mM TMAO (closed circles). The 
details of the assembly conditions were described 
in the Materials and Methods section. 
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suggests a direct role for TMAO in the increase of cellular 
microtubules. 
TMAO Does Not Change Total Tubulin in Cells 
Hypertonic shock can induce intracellular 
alkalinization (19). Alkalinization in Xenopus oocytes 
results in an increase of protein synthesis (20). Tubulin 
synthesis might be affected by the presence of TMAO and 
affect microtubule assembly through this alkalinization 
mechanism. We examined the total P-tubulin in TMAO-treated 
cells (200 mM TMAO, 6 hours) with an immunoblotting assay. 
A fixed number of cells with or without TMAO treatment was 
analyzed. The results of densitometric measurements for 
total area intensity and peak intensity are shown in Table 
1. The total and peak intensities for both blots are 
similar (Table 1). This immunoblotting result suggests that 
total cellular tubulin amounts are unchanged or slightly 
decrease in TMAO-treated cells. Therefore, it is unlikely 
that the change in microtubule assembly is due to an 
increase in total cellular tubulin. 
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Table 1. Densitometric analysis of P-tubulin immunoblots. 
The proteins in cell extracts of XRl cells with/without TMAO 
treatment (200 mM, 5 hours) were separated by electrophoresis and 
blotted onto a PVDF membrane. After color development, the PVDF 
membrane was scanned by a GS-670 imaging densitometer. The 
scanned images were analyzed using the software of the Molecular 
Analyst version 1. 
Cell Extracts Area Peak 
TMAO-Treated Cells 22.7 0.20 
Control Cells 24.6 0.21 
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F-actiji Organization Remains Intact in TMAO-Treated Cells 
Inasmuch as TMAO is capable of assisting the 
polymerization of microtubules, we investigated whether TMAO 
could act on another cytoskeletal assembly system, F-actin. 
Hypertonic osmotic shock induced by salts is known to 
disturb the F-actin cytoskeleton of C6 glial cells (21). We 
analyzed cellular F-actin of XRl cells using rhodamine-
conjugated phalloidin that binds F-actin. 
Results showed that the F-actin fibers in TMAO-treated 
cells (200 mM TMAO, 6 hours) do not exhibit a significant 
difference in organization (Fig. 4a and b) compared with 
those in control cells (Fig. 4c and d). The F-actin stress 
fibers in both TMAO-treated cells and control cells are 
relatively straight. Many fibers extend from one side of 
the cells to the other side. We did not observe any 
significant decrease in the length of F-actin fibers as was 
reported earlier in hypertonic shocked cells (21). The 
distributions of stress fibers and cortical fibers was 
similar in both TMAO-treated cells and control cells. The 
diameters of all fibers appeared to be uniform. There was 
no obvious change in the amount of F-actin in TMAO-treated 
cells as assessed by rhodamine fluorescent staining although 
we did not analyze the relative amounts of G-actin and F-
Figure 4. Fluoresence images illustrating rhodamine-
phalloidin labeling in XRl glial cells. XRl cells 
in a and b were treated with 200 mM TMAO for 6 
hours. c and d are photomicrographs of control 
cells. Images in a and c were captured using a 
2OX objective. Images in b and d are at higher 
magnification (40X objective). The calibration 
bars in a and b correspond to 50 }lm and 25 |im, 
respectively. 
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actin using biochemical analysis. The rhodamine-phalloidin 
staining results suggest that TMAO does not cause any 
apparent change in cellular F-actin. 
Glycerol Does Not Increase Cellular Microtubule Assembly and 
F-actins 
To determine whether the microtubule increase is 
specific to TMAO, we tested glycerol on XRl cells. Glycerol 
is a polyol osmolyte and is well known to stabilize 
microtubules in vitro (22, 23). Microtubules and F-actin of 
glycerol-treated cells (200 mM, 6 hours) were examined, 
using the fluorescent staining procedures as described 
previously. The fluorescent staining images are shown in 
Fig. 5. 
Immunofluorescent staining results show that there is a 
decrease in the ^-tubulin immunostaining between glycerol-
treated cells (Fig. 5a) and control cells (Fig. 5b). The 
actin organization in glycerol-treated cells (Fig. 5c) is 
similar to that in control cells (Fig. 5d). The F-actin 
staining in some glycerol-treated cells is somewhat weaker 
than that in control cells. The diameters of F-actin fibers 
in both cells are also similar. Nevertheless, we conclude 
that the osmotic shock induced by 200 mM glycerol does not 
Figure 5. The immunofluorescent labeling of XRl cells by E7 
antibodies against P-tubulin {a, b) oi: rhodamine-
conjugated phalloidin (c, d). a and c are 
photomicrographs of XRl cells treated with 200 mM 
glycerol-mediiam for 6 hours; b and d, cells 
treated with control media. All images were 
captured using a 40X oil immersion objective. 
Calibration bar, 25 (im. 
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increase microtubule assembly and has no effect on actin 
organization in XRl cells. 
Discussion 
The results shown in the previous section support our 
hypothesis that TMAO at physiological concentrations can 
promote cellular microtubule assembly. 
TMAO increases the rate and extent of microtubule 
formation in vitro, suggesting a thermodynamic role for TMAO 
(1). Lee and Timasheff proposed that tubulin-critical 
concentrations could be treated as thermodynamic indexes for 
assembly (22, 23). Deteinnination of the tubulin-critical 
concentration shows that TMAO can lower the critical 
concentrations for tubulin self-assembly and microtubule-
associated protein tau-tubulin assembly in vitro (18). This 
means that TMAO drives the microtubule-associated protein-
microtubule assembly process forward. Here, we have 
demonstrated that there is an increase in cellular 
microtubules (Fig. 1) in the presence of intracellular TMAO 
(Fig. 2). These results suggest that intracellular TMAO can 
generate an environment that favors the formation of 
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microtubules by lowering the tubulin-critical concentration 
in cells. 
The intracellular TMAO concentration of cells in Fig. 
Ic is estimated to be within a range of 30-5 0 mM (see 
Results section). This concentration range is well below 
the TMAO concentration in the culture medium. The longest 
incubation time with TMAO described in this report was 6 
hours. Cells may accumulate additional TMAO after 6 hours. 
The accumulation of organic osmolytes, such as betaine, 
usually takes hours (6). The observed accumulation of TMAO 
in XRl cells was also slow, as was the removal of 
intracellular TMAO. The mechanism for TMAO translocation 
remains unclear. Nevertheless, intracellular TMAO with SO-
SO mM is clearly sufficient to promote microtubule assembly 
(Fig. Ic). This assembly stimulation by a low TMAO 
concentration can be reproduced in a tau-tubulin assembly 
system (Fig. 3), but not in the tubulin self-assembly system 
(14). These results suggest that the assembly stimulation 
caused by low concentrations of TMAO in cells is being 
assisted by MAPs, such as tau. Besides, TMAO concentration 
as high as 200 mM can be found in many marine animals (2). 
It can be expected that TMAO in those animals has a 
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significant effect on cellular microtubules to counteract 
the deleterious effect of urea. 
Betaine is an important osmolyte in renal medulla (6) 
and is structurally similar to TMAO. Betaine can counteract 
the denaturing effects caused by urea (24, 25). Although 
betaine does not promote tubulin self-assembly (14), it does 
promote MAP-tubulin assembly in vitro (1) . Because MAPS are 
ubiquitous in cells, it is possible that betaine can promote 
cellular microtubule assembly by a mechanism similar to 
TMAO. 
Hypertonic shock induced by 400 mOsm NaCl can affect F-
actin in C6 glial cells (21). We also found that XRl glial 
cells detached from culture substrates containing an 
additional 100 mM NaCl, implying an abnormality in F-actin 
(data not shown). The intact organization of F-action in 
Fig. 4, however, indicates that TMAO does not induce the 
disassembly of F-actin. Osmotic shock induced by glycerol 
does not increase microtubule assembly (Fig. 5a). In many 
cases, the amount of microtubules in glycerol-treated cells 
is less than that in control cells (Fig. 6a and b). The 
microtubule increase caused by TMAO can not be explained 
simply by common hypertonic shock. 
Ill 
Hypertonic osmotic stress with salts can activate 
stress-activated protein kinase (SAPK)/c-Jun N-terminal 
kinase (JNK) (26), and p38 mitogen-actived protein kinase 
(MAPK) (26, 27) cascades in kidney cells. The activation of 
SAPK and MAPK is also seen in PC12 cells with salt 
hypertonic shock (28) . MAPKs are believed to be involved in 
cytoskeleton reorganization (29). The interphase-M phase 
transition of microtubule dynamics can be induced by the 
addition of purified Xenopus M phase MAPK to interphase 
extracts (30). Microtubule-associated protein 2 is a good 
substrate for MAPKs (29) . p38 MAPK and stress-activated 
kinase/c-Jun kinase can phosphorylate the MAP tau (31-33). 
Hyperphosphorylation or abnormal phosphorylation of tau is 
believed to lead to disruption of microtubules that may 
occur in Alzheimer's disease (34-37). Hypertonic osmotic 
stress can increase phosphorylation of tau and affect 
microtubule dynamics in SH—SY5Y neuroblastoma cells (38). 
These results suggest that phosphorylation on tau may also 
increase in XRl cells with a hypertonic stress. Recently, 
Tseng et al. demonstrated that TMAO was able to compensate 
for the functional deficit of phosphorylated tau to promote 
tubulin assembly In vitro, using spectrometric and atomic 
force microscopy measurements (18). We propose that XRl 
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cells with TMAO hypertonic shock may have higher SAPK and/or 
MAPK activities that will result in the phosphorylation of 
MAPS. In addition to assembly caused by non-phosphorylated 
microtubule-associated protein-tubulin assembly, 
intracellular TMAO may also promote tubulin assembly by 
phosphorylated MAPs in TMAO-treated cells. But the 
determination of kinase activities and the phosphorylation 
of MAPS are needed to verify this speculation. Studies on 
the effects of protein phosphorylation of MAP on tubulin 
assembly in these cells are currently being carried out in 
our laboratory. 
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CHAPTER 5 
GENERAL SUMMARY AND DISCUSSION 
Urea-rich cells contain high concentrations of 
methylamine osmolytes to counteract the effects of urea (53-
56). Urea inhibits microtubule (MT) assembly in vivo and in 
vitro (65, 66). Before my research reported in this 
dissertation, little was known about what strategy urea-rich 
cells may use to maintain their microtubules in the presence 
of high concentrations of urea. 
In this dissertation, results in Chapter 2 show that 
methylamine including TMAO and betaine can stimulate 
microtubule-associated protein (MAP) tau-tubulin asseitibly 
and counteract the effects of urea on tau-tubulin assembly. 
The concentration of TMAO used in the in vitro experiments 
is at a physiological level, 200 mM, found in elasmobranchs 
(53, 54). This concentration of TMAO alone did not promote 
tubulin assembly at a tubulin concentration of 1 mg/ml but 
needs the presence of tau in order to show its effect. TMAO 
changes the rate and extent of tau-tubulin assembly, 
suggesting a change in energetics of assembly. This 
suggestion is supported by a critical concentration 
determination in Chapter 3. TMAO is able to lower the 
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tubulin-critical concentrations for either tubulin self-
assembly or tau-tubulin assembly. Free energies for tubulin 
assembly and tau-tubulin assembly are lowered by the 
presence of TMAO because the tubulin-critical concentration 
is related to the free energy of the assembly (shown as the 
following equation) (67). 
AG = - RT In (Cr)"^ 
AG standard free energy 
R: gas constant T: absolute temperature 
Cr: tubulin-critical concentration 
The increase of MTs caused by TMAO also occurs in 
cells, shown in Chapter 4. The MTs of XRl glial cells are 
increased when culture media contain TMAO. The increase of 
MTs can be reversed by the removal of TMAO from culture 
media. Importantly, evidences from ^H-NMR measurement show 
that TMAO is present inside these cells if cells are 
incubated with TMAO-media. The intracellular TMAO and 
microtubule increase are correlated, supported by the 
results of tubulin-immunofluorescent labeling, ^H-NMR 
measurement and in vitro tubulin assembly in Chapter 4. 
Based on these results, I conclude that TMAO can promote 
cellular microtubule assembly. 
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The concentration of intracellular TMAO in the XRl 
glial cells that are treated with 200 itiM TMAO for 6 hours is 
estimated to be 30-50 mM. This concentration is much less 
than that used to enhance tubulin self-assembly (65). It is 
observed that cellular microtubule assembly is enhanced by 
this concentration of TMAO, shown in Chapter 4. In 
elasmobranchs, intracellular concentration of TMAO is as 
high as 200 mM (53). It may be expected that TMAO in 
elasmobranchs can enhance microtubules in order to 
counteract the deleterious effect caused by urea. Tau is 
always required in my in vitro assembly system in order to 
show that low concentration of TMAO can promote microtubule 
assembly. Glial cells, like neurons, express several 
microtubule-associated proteins including MAP2 and tau. It 
is likely that microtubule-associated proteins in XRl cells 
contribute to the increase of cellular microtubules caused 
by TMAO. 
Phosphorylation on tau can reduce tau's ability to 
promote tubulin assembly (39, 43, 44). PKA-phosphorylated 
tau and GSK-3P-phosphorylated tau lose their stimulation of 
tubulin assembly. Although phosphorylation sites in both 
the PKA-phosphorylated tau and GSK-3P-phosphorylated tau used 
in my studies are not completely defined, preliminary mass 
123 
spectrometry studies show that Ser-214 and Ser-356 are major 
sites of phosphorylation in PKA-phosphorylated tau. This 
preliminary result is consistent with previous reports 
(Table 1, in Chapter 1). The functional deficit can be 
compensated by TMAO (Fig. 1). TMAO does not cause chemical 
dephosphorylation on tau. PKA-phosphorylated tau (with 2.6 
mol phosphate/mol tau) does not change tubulin critical 
concentration, indicating no interaction or little 
interaction between this phosphorylated tau and tubulin. 
However, the addition of TMAO to the assembly mixture 
containing the PKA-phosphorylated tau significantly lowers 
tubulin critical concentration for assembly. These results 
suggest that phosphorylated tau can interact with tubulin 
and promote tubulin assembly. A result of microtubules 
incubated with ^^P-labeled tau indicates that the 
microtubules contain phosphorylated tau. Microtubules 
containing PKA-phosphorylated tau (with 2.7 mol 
phosphate/mol tau) look like the microtubules containing 
non-phosphorylated tau, as judged by atomic force 
microscopy. If the phosphorylation stoichiometry of PKA-
phosphorylated tau reaches 4.0 mol phosphate/mol, the 
phosphorylated tau-microtubules in the presence of TMAO 
appears deformed (Fig. 2). The change of the apparent 
Figure 1. Model of the effect of TMAO on microtubule-
associated protein tau-tubulin assembly. 
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Figure 2. Atomic force microscopic (AFM) image of tau-
tubulin assembly. Tubulin and PKA-phosphorylated 
tau with 4.0 phosphates/mole were assembled using 
the standard reaction condition. The fixed 
mixture was then spotted onto a mica disc, dried 
and scanned by AFM. 
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persistence length of microtubules indicates that some 
phosphorylation reactions of tau can change the 
characteristics of assembled microtubules containing 
phosphorylated tau. How TMAO might force phosphorylated 
tau-microtubule assembly is suggested in Chapter 3. The 
mechanisms for the action of TMAO on phosphorylated proteins 
remain unclear. 
Hypertonic stress can activate stress-activated protein 
kinases (SAPK), and mitogen-activated protein kinases (MAPK) 
in cells (68-70). These two kinases can phosphorylate 
microtubule-associated proteins tau (46, 71-73) and result 
in microtubule reorganization (74, 75). This microtubule 
decrease is also observed in XRl cells if cells were 
incubated in media containing additional 200 mM glycerol, 
200 mM NaCl or 200 mM glycine (Fig.3). However, XRl cells 
incubated in 200 mM TMAO medium have more microtubules. 
Based on results in Chapter 3, intracellular TMAO may be 
able to compensate the functional deficit of phosphorylated 
microtubule-associated proteins, and maintain microtubules 
in hypertonic shocked cells. 
Hyperphosphorylation or abnormal phosphorylation of tau 
has been proposed as one potential cause of Alzheimer's 
disease (43, 44). In the patients' brains, paired helical 
Figure 3. Immunofluorescent analysis of microtubules in XRl 
cells by E7 antibodies against p-tubulin. Cells in 
a were treated with 200 mM glycine media for 6 
hours; cells in b, control media. The 
immunofluorescent labeling in a and b represents 
the structure of cellular microtubules. 
Calibration bar, 25 ^m. 
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filaments (PHFs), one of the major hallmarks, mainly consist 
of tau proteins (76, 77). Tau proteins in PHFs are 
hyperphosphoiiYlated. The phosphorylation stoichiometry on 
normal brain tau is 2-3 moles phosphate/mole of the protein 
but that on Alzheimer's tau is approximately 5-9 moles 
phosphate/mole of the protein (43). Before research 
reported in Chapter 3, removing the phosphates from tau 
through phosphatase dephosphorylation is the only way to 
recovery the tau's biological function (76). Now, TMAO is 
shown to be able to compensate the functional deficit of 
phosphorylated tau without the removal of phosphates. The 
compensation is not specifically limited to a certain type 
of phosphorylation (see Chapter 3). Therefore, TMAO may be 
used as a new tool to study MT disassembly in 
neurodegenerative diseases, such as Alzheimer's disease, 
caused by abnormal phosphorylation on microtubule-associated 
proteins. Several single mutations, such as G272V, V279M, 
P301L, V337M, within microtubule-binding domain of tau was 
found in frontotemporal dementia patients and has been 
proposed to be the cause of frontotemporal dementia (78-81). 
The mutant tau (P301L, V337M) has less binding affinity to 
taxol-stabilized microtubules (80). Since TMAO can rescue 
the PKA-phosphorylated tau containing Ser-356 
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phosphorylation in microtubule-binding domain (Chapter 3), 
TMAO may have chances to compensate those mutants. This idea 
is supported by the fact that TMAO can correct the protein 
folding in a cystic fibrosis study (82). One application of 
TMAO on scrapie-infected mouse neuroblastoma (ScN2a) cells 
also shows that TMAO can prevent the formation of pathogenic 
form of prion proteins (83). 
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